Research progress on coronary slow flow or no-reflow of coronary heart disease undergoing percutaneous coronary intervention surgery
Coronary heart disease (CHD), a prevalent cardiovascular disorder, poses a significant threat to human health.Particularly, ST-segment elevation myocardial infarction (STEMI) is associated with a higher mortality rate.Timely and effective revascularization of the culprit vessels is crucial.Percutane...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of International Journal of Geriatrics
2025-01-01
|
| Series: | Guoji laonian yixue zazhi |
| Subjects: | |
| Online Access: | http://gwll.publish.founderss.cn/thesisDetails#10.3969/j.issn.1674-7593.2025.01.021&lang=en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Coronary heart disease (CHD), a prevalent cardiovascular disorder, poses a significant threat to human health.Particularly, ST-segment elevation myocardial infarction (STEMI) is associated with a higher mortality rate.Timely and effective revascularization of the culprit vessels is crucial.Percutaneous coronary intervention (PCI) is a preferred and critical treatment modality for STEMI patients, effectively addressing vascular obstruction.However, a subset of patients experiences coronary slow flow (CSF) or no-reflow (NR) postoperatively, which severely impacts their prognosis.This article provides a comprehensive review of the definition, diagnosis, epidemiology, predictive factors, mechanisms, and treatment of CSF/NR, aiming to offer guidance for the clinical management of these complications following PCI in CHD patients. |
|---|---|
| ISSN: | 1674-7593 |